<html>
<head>PUBMED IDs for LGMD2D</head>
<body bgcolor='#C5F0F2'><h1>LGMD2D</h1><a href='https://pubmed.ncbi.nlm.nih.gov/8825917/'>Estimate of severe autosomal recessive limb-girdle muscular dystrophy (LGMD2C, LGMD2D) among sporadic muscular dystrophy males: a study of 415 familes.</a> December 1  1995<br><a href='https://pubmed.ncbi.nlm.nih.gov/8899051/'>Limb-girdle muscular dystrophy: a follow-up study of 79 patients.</a> September 1  1996<br><a href='https://pubmed.ncbi.nlm.nih.gov/8899049/'>Mitochondrial DNA mutations in multiple sclerosis patients with severe optic involvement.</a> September 1  1996<br><a href='https://pubmed.ncbi.nlm.nih.gov/8899048/'>Distribution of HLA-Dw2 in optic neuritis and multiple sclerosis indicates heterogeneity.</a> September 1  1996<br><a href='https://pubmed.ncbi.nlm.nih.gov/8943294/'>Characterization of delta-sarcoglycan, a novel component of the oligomeric sarcoglycan complex involved in limb-girdle muscular dystrophy.</a> December 13  1996<br><a href='https://pubmed.ncbi.nlm.nih.gov/10069710/'>Seven autosomal recessive limb-girdle muscular dystrophies in the Brazilian population: from LGMD2A to LGMD2G.</a> March 9  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10385046/'>Sarcoglycanopathies are responsible for 68% of severe autosomal recessive limb-girdle muscular dystrophy in the Brazilian population.</a> June 29  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10619713/'>A diagnostic fluorescent marker kit for six limb girdle muscular dystrophies.</a> January 5  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/10842281/'>Partial alpha-sarcoglycan deficiency with retention of the dystrophin-glycoprotein complex in a LGMD2D family.</a> June 8  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11555999/'>[LGMD2C, LGMD2D, LGMD2E, LGMD2F].</a> September 15  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/14959561/'>Molecular bases of autosomal recessive limb-girdle muscular dystrophies.</a> February 13  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15298081/'>Respiratory insufficiency as a presenting symptom of LGMD2D in adulthood.</a> August 10  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15298080/'>Myokimia and potassium channel gene Kv1.1.</a> August 10  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15316618/'>[Limb girdle muscular dystrophies].</a> August 19  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15547664/'>Evaluation of sarcoglycans, vinculin-talin-integrin system and filamin2 in alpha- and gamma-sarcoglycanopathy: an immunohistochemical study.</a> November 18  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15651352/'>[Limb-girdle muscular dystrophy; update].</a> January 18  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15736300/'>Enrichment of the R77C alpha-sarcoglycan gene mutation in Finnish LGMD2D patients.</a> March 1  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/17164775/'>Phenotypic correction of alpha-sarcoglycan deficiency by intra-arterial injection of a muscle-specific serotype 1 rAAV vector.</a> December 14  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/28182933/'>Phenotypic Correction of α-Sarcoglycan Deficiency by Intra-arterial Injection of a Muscle-specific Serotype 1 rAAV Vector.</a> January 1  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/28182933/'>Phenotypic Correction of α-Sarcoglycan Deficiency by Intra-arterial Injection of a Muscle-specific Serotype 1 rAAV Vector.</a> January 1  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17994539/'>Clinical, molecular, and protein correlations in a large sample of genetically diagnosed Italian limb girdle muscular dystrophy patients.</a> November 13  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18252746/'>A common disease-associated missense mutation in alpha-sarcoglycan fails to cause muscular dystrophy in mice.</a> February 7  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18252745/'>Mannosidase I inhibition rescues the human alpha-sarcoglycan R77C recurrent mutation.</a> February 7  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18525034/'>Lack of toxicity of alpha-sarcoglycan overexpression supports clinical gene transfer trial in LGMD2D.</a> June 6  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18996010/'>Sarcoglycanopathies: can muscle immunoanalysis predict the genotype?</a> November 11  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/21856579/'>Founder mutation for α-sarcoglycan-LGMD2D in a Magdalen Islands Acadian cluster.</a> December 13  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22303798/'>The first case of primary alpha-sarcoglycanopathy identified in Albania, in two siblings with homozygous alpha-sarcoglycan mutation.</a> March 7  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22745439/'>Transplantation of genetically corrected human iPSC-derived progenitors in mice with limb-girdle muscular dystrophy.</a> October 27  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/24843229/'>Genetic basis of limb-girdle muscular dystrophies: the 2014 update.</a> August 2  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25106685/'>Clinical and molecular description of a 17q21.33 microduplication in a girl with severe kyphoscoliosis and developmental delay.</a> June 13  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26450518/'>Progress and prospects of gene therapy clinical trials for the muscular dystrophies.</a> February 9  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26916285/'>Precise Correction of Disease Mutations in Induced Pluripotent Stem Cells Derived From Patients With Limb Girdle Muscular Dystrophy.</a> December 27  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/26944168/'>Probable high prevalence of limb-girdle muscular dystrophy type 2D in Taiwan.</a> December 15  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/26944167/'>Blepharospasm in a multiplex African-American pedigree.</a> December 15  2016<br></body></html>
